Hemostasis Today

November, 2026
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Alok Khorana: First FXI Inhibitor Approved in the US
Nov 20, 2026, 11:03

Alok Khorana: First FXI Inhibitor Approved in the US

Alok Khorana, Vice Chair of the Taussig Cancer Institute at Cleveland Clinic, shared a post on LinkedIn:

“Big news that the first FXI inhibitor is finally approved, at least in the US.

Asundexian is approved for use after ischemic stroke, to reduce recurrent events.

Bleeding was no different than placebo (1.9% vs. 1.7%; P = 0.46).

Trials of various FXI inhibitors are currently ongoing in a variety of cancer settings (primary and secondary prevention of thrombosis), with the hope of reducing bleeding but preserving anticoagulant efficacy.”

Alok Khorana

Stay updated with Hemostasis Today.